Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 2 of 2: Calculated dose response metrics - Dataset (ID:20344)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Primary Target | Pathway | GR50 | GRmax | GR_AOC | Death_AUC | GR Hill Coefficient | GEC50 | GR r2 |
---|---|---|---|---|---|---|---|---|---|---|
PDX1328 | Palbociclib | CDK4/6 | Cell cycle | 0.028878 | 0.1110 | 0.4289 | -0.0020 | 1.3039 | 0.020889 | 0.9674 |
PDX1328 | AZD7762 | CHK1/2 | Cell cycle | 0.035587 | -0.8228 | 0.8326 | 0.1855 | 1.2761 | 0.066257 | 0.96822 |
PDX1328 | Volasertib | PLK | Cell cycle | 0.0025124 | -0.5731 | 0.9694 | 0.2182 | 2.8453 | 0.0032751 | 0.99856 |
PDX1328 | Dinaciclib | pan CDK | Cell cycle | 0.011496 | -0.7107 | 0.7519 | 0.2292 | 3.5560 | 0.014708 | 0.9982 |
PDX1328 | Cisplatin | Chemo | Chemotherapy | 0.77968 | -0.4217 | 0.3154 | 0.0259 | 1.3251 | 1.2886 | 0.9879 |
PDX1328 | Doxorubicin | Chemo | Chemotherapy | 0.013267 | -0.7789 | 0.8023 | 0.1468 | 1.4934 | 0.021574 | 0.96338 |
PDX1328 | Taxol | Chemo | Chemotherapy | 0.002983 | -0.5332 | 0.9047 | 0.1888 | 3.1886 | 0.0036802 | 0.98401 |
PDX1328 | Topotecan | Topo I | Chemotherapy | 0.0059222 | -0.9128 | 1.0720 | 0.1509 | 0.4616 | 0.063175 | 0.94441 |
PDX1328 | Etoposide | Topo II | Chemotherapy | 0.80493 | -0.2805 | 0.3502 | 0.0172 | 1.4732 | 1.1571 | 0.98432 |
PDX1328 | Dasatinib | BCR/ABL | MAPK/nRTK | 0.035818 | -0.3368 | 0.6929 | 0.0612 | 0.7466 | 0.064434 | 0.94799 |
PDX1328 | Trametinib | MEK | MAPK/nRTK | 0.018054 | 0.2490 | 0.3349 | 0.0167 | 1.3148 | 0.0076303 | 0.97089 |
PDX1328 | Saracatinib | SRC | MAPK/nRTK | 0.82476 | -0.0349 | 0.3256 | 0.0293 | 0.4526 | 9.3443 | 0.92264 |
PDX1328 | ABT-737 | Bcl2/XL | Misc | 1.0279 | -0.8967 | 0.3548 | 0.1542 | 1.3255 | 2.3546 | 0.97784 |
PDX1328 | Vorinostat | HDAC | Misc | 0.41708 | -0.5588 | 0.4597 | 0.0854 | 1.1909 | 0.83181 | 0.99216 |
PDX1328 | Luminespib | HSP90 | Misc | 0.0023764 | -0.4697 | 0.8697 | 0.1444 | 1.9222 | 0.0032941 | 0.9864 |
PDX1328 | A-1210477 | Mcl-1 | Misc | 29.0724 | 0.7094 | 0.0609 | 0.0135 | 0.6451 | 128.4233 | 0.82503 |
PDX1328 | Olaparib | PARP | Misc | Inf | 0.7634 | 0.0268 | -0.0025 | 5.0000 | 1.7254 | 0.86133 |
PDX1328 | Bleomycin | Radiation | Misc | 4.0022 | 0.3061 | 0.1994 | 0.0033 | 0.4524 | 45.3783 | 0.95786 |
PDX1328 | Ipatasertib | AKT | PI3K/mTOR | 4.7978 | 0.3012 | 0.1323 | 0.0153 | 0.6377 | 26.7942 | 0.95509 |
PDX1328 | Alpelisib | PI3Ka | PI3K/mTOR | 0.31193 | -0.0050 | 0.3735 | 0.0319 | 0.8438 | 0.32361 | 0.95669 |
PDX1328 | Taselisib | PI3Ka, g, d | PI3K/mTOR | 0.0071031 | -0.2439 | 0.7440 | 0.0558 | 0.2650 | 0.08641 | 0.88652 |
PDX1328 | TGX221 | PI3Kb | PI3K/mTOR | 22.8162 | 0.7594 | 0.0116 | 0.0024 | 1.1153 | 60.9221 | 0.6986 |
PDX1328 | Torin2 | mTOR/ATM/ATR | PI3K/mTOR | 0.0028919 | -0.3715 | 0.7187 | 0.0739 | 0.8875 | 0.004646 | 0.98005 |
PDX1328 | Everolimus | mTOR1 | PI3K/mTOR | Inf | 0.2825 | 0.6902 | 0.0347 | 0.0000 | Inf | 0.15246 |
PDX1328 | INK-128 | mTORC1/2 | PI3K/mTOR | 0.0042182 | -0.2955 | 0.8098 | 0.0628 | 1.2155 | 0.0054971 | 0.99054 |